Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis

  • Codony, Sandra
  • Calvó-Tusell, Carla
  • Valverde, Elena
  • Osuna, Sílvia
  • Morisseau, Christophe
  • Loza García, María Isabel
  • Brea Floriani, José Manuel
  • Pérez, Concepción
  • Rodríguez-Franco, María Isabel
  • Pizarro-Delgado, Javier
  • Corpas, Rubén
  • Griñán-Ferré, Christian
  • Pallàs, Mercè
  • Sanfeliu, Coral
  • Vázquez-Carrera, Manuel
  • Hammock, Bruce D.
  • Feixas, Ferran
  • Vázquez, Santiago
The pharmacological inhibition of soluble epoxide hydrolase (sEH) is efficient for the treatment of inflammatory and pain-related diseases. Numerous potent sEH inhibitors (sEHIs) present adamantyl or phenyl moieties, such as the clinical candidates AR9281 or EC5026. Herein, in a new series of sEHIs, these hydrophobic moieties have been merged in a benzohomoadamantane scaffold. Most of the new sEHIs have excellent inhibitory activities against sEH. Molecular dynamics simulations suggested that the addition of an aromatic ring into the adamantane scaffold produced conformational rearrangements in the enzyme to stabilize the aromatic ring of the benzohomoadamantane core. A screening cascade permitted us to select a candidate for an in vivo efficacy study in a murine model of cerulein-induced acute pancreatitis. The administration of 22 improved the health status of the animals and reduced pancreatic damage, demonstrating that the benzohomoadamantane unit is a promising scaffold for the design of novel sEHIs.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Proinsulin protects against age-related cognitive loss through anti-inflammatory convergent pathways

  • Corpas, Rubén
  • Hernández-Pinto, Alberto M.
  • Porquet, David
  • Hernández-Sánchez, Catalina
  • Bosch, Fátima
  • Comellas, Francesc
  • De la Rosa, Enrique J.
  • Sanfeliu, Coral
40 p.-5 fig., Brain inflammaging is increasingly considered as contributing to age-related cognitive loss and neurodegeneration. Despite intensive research in multiple models, no clinically effective pharmacological treatment has been found yet. Here, in the mouse model of brain senescence SAMP8, we tested the effects of proinsulin, a promising neuroprotective agent that was previously proven to be effective in mouse models of retinal neurodegeneration. Proinsulin is the precursor of the hormone insulin but also upholds developmental physiological effects, particularly as a survival factor for neural cells. Adeno-associated viral vectors of serotype 1 bearing the human proinsulin gene were administered intramuscularly to obtain a sustained release of proinsulin into the blood stream, which was able to reach the target area of the hippocampus. SAMP8 mice and the control strain SAMR1 were treated at 1 month of age. At 6 months, behavioral testing exhibited cognitive loss in SAMP8 mice treated with the null vector. Remarkably, the cognitive performance achieved in spatial and recognition tasks by SAMP8 mice treated with proinsulin was similar to that of SAMR1 mice. In the hippocampus, proinsulin induced the activation of neuroprotective pathways and the downstream signaling cascade, leading to the decrease of neuroinflammatory markers. Furthermore, the decrease of astrocyte reactivity was a central effect, as demonstrated in the connectome network of changes induced by proinsulin. Therefore, the neuroprotective effects of human proinsulin unveil a new pharmacological potential therapy in the fight against cognitive loss in the elderly., This work was supported by grants: CSD2010-00045 to CS and EJdlR, from the Spanish Ministerio de Economía y Competitividad (MINECO), SAF2016-77703-C2-2-R to CS and MTM2014-60127-P to FC from MINECO and European Regional Development Fund (ERDF), and TRACE (PET08-0282) to FB and EJdlR, from the Spanish Ministerio de Ciencia e Innovación (MICINN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Neurotransmitter amines and antioxidant agents in neuronal protection against methylmercury-induced cytotoxicity in primary cultures of mice cortical neurons

  • Olguín, Nair
  • Müller, Marie-Lena
  • Rodríguez-Farré, Eduard
  • Suñol, Cristina
Methylmercury (MeHg) is an environmental toxicant with detrimental effects on the developing brain and adult nervous system. The main mechanisms identified include oxidative stress, changes in intracellular calcium, mitochondrial changes, inhibition of glutamate uptake, of protein synthesis and disruption of microtubules. However, little is known about mechanisms of protection against MeHg neurotoxicity. We found that resveratrol (10 μM) and ascorbic acid (200 μM) protected MeHg-induced cell death in primary cultures of cortical neurons. In this work, we aimed at finding additional targets that may be related to MeHg mode of action in cell toxicity with special emphasis in cell protection. We wonder whether neurotransmitters may affect the MeHg effects on neuronal death. Our findings show that neurons exposed to low MeHg concentrations exhibit less mortality if co-exposed to 10 μM dopamine (DA). However, DA metabolites, HVA (homovanillic acid) and DOPAC (3,4-dihydroxyphenylacetic acid) are not responsible for such protection. Furthermore, both DA D1 and D2 receptors agonists showed a protective effect against MeHg toxicity. It is striking though that DA receptor antagonists SKF83566 (10 μM) and haloperidol (10 μM) did not inhibit DA protection against MeHg. In addition, the protective effect of 10 μM DA against MeHg-induced toxicity was not affected by additional organochlorine pollutants exposure. Our results also demonstrate that cells exposed to MeHg in presence of 100 μM acetylcholine (ACh), show an increase in cell mortality at the “threshold value” of 100 nM MeHg. Finally, norepinephrine (10 μM) and serotonin (20 μM) also had an effect on cell protection. Altogether, we propose to further investigate the additional mechanisms that may be playing an important role in MeHg-induced cytotoxicity., This research was supported by the Spanish projects PI13/01252 and PI15/00033 from the Instituto de Salud Carlos III and SAF2016-77703-C2-2-R from MINECO, cofinanced with European Social Funds “A Way to build Europe”, and the 2017/SGR/106 and CERCA Programme from the Generalitat of Catalunya. N.O. is recipient of a CSIC JAE-Doc contract from the “Junta para la Ampliación de Estudios” Program cofinanced with European Social Funds, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Proinsulin therapy protects against neuroinflammaging and cognitive loss in senescence-accelerated mice

  • Sanfeliu, Coral
  • Corpas, Rubén
  • Hernández-Pinto, Alberto M.
  • Porquet, David
  • Hernández-Sánchez, Catalina
  • Bosch, Fátima
  • Ortega-Aznar, Arantxa
  • Comellas, Francesc
  • De la Rosa, Enrique J.
Trabajo presentado en el IUBMB Focused Meeting on «Molecular aspects of aging and longevity», celebrado en Atenas, del 16 al 19 de octubre de 2017, Chronic low-grade neuroinflammation is tightly associated with brain age-related changes and it is considered a crucial derangement that paves the way to neurodegeneration and dementia. Among other ailments, inflammation may lead to insulin resistance that is a risk factor for Alzheimer’s disease. In this scenario, the hormone precursor proinsulin may have a potential pharmacological use in preventing neuronal death. Proinsulin is a bioactive molecule regulating neural cell death in embryonic processes and it was proven neuroprotective in mouse models of retinal neurodegeneration. We aimed to prove the geroprotective effect of a chronic proinsulin treatment against neuroinflammaging and memory loss in the senescence-accelerated mouse SAMP8. We used a gene therapy procedure through peripheral muscle transduction with an adeno-associated viral vector bearing the human proinsulin gene (AAV-hPi) that yielded sustained release of proinsulin into the bloodstream. One-month old male mice of the SAMP8 strain and the control strain SAMR1 were injected with AAV-hPi or AAV-null vectors. At 6 months of age, proinsulin-treated SAMP8 mice showed totally preserved cognitive capacities both in spatial and recognition paradigms of learning and memory, in contrast to those SAMP8 mice injected with the null vector. Hippocampus analysis showed that proinsulin activated Akt and ATF1/CREB signaling pathways in both SAMR1 and SAMP8 mice. Furthermore, we identified a significant decrease of neuroinflammatory markers in the hippocampus of SAMP8 mice to levels of SAMR1 mice. Strikingly, the marker of astrocyte reactivity GFAP was decreased in both SAMR1 and SAMP8. Furthermore, the connectome network build with all changes induced by proinsulin showed that the decrease of astrocyte reactivity was a central effect in proinsulin neuroprotection. Therefore, the preventive and protective effects of human proinsulin against neuroinflammaging and senescence-related cognitive loss unveil a potential geroprotective therapy to increase healthy brain aging., This study was supported by CSD2010-00045, SAF2016-77703-C2-2-R, MTM2014-60127-P, MINECO and ERDF; PET08-0282, TRACE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis de maestría (MasterThesis)

Neuroprotective mechanisms of resveratrol in a high-fat diet-fed Alzheimer's disease mouse model

  • Gatius, Alaó
Over the last decades there has been an over consumption of foods rich in animal fats that has led to a global obesity pandemic. Obesity presents itself with a number of comorbidities, including an increased risk for the development of neurodegenerative disorders such as Alzheimer’s disease (AD). On the other hand, reducing caloric intake has showed to delay age-related diseases and resveratrol, a polyphenol produced by a variety of plants, has emerged as a potent mimetic of this caloric restriction. The mechanisms underlying both effects are not fully understood and, as potential therapeutic targets, need to be thoroughly analyzed. To this end, we have analyzed molecular pathways involved in memory loss in mice as a result of a high-fat diet (HFD) administration and the role that resveratrol supplementation on this diet may play. We have focused on 6-months-old 5xFAD mice, which are transgenic AD mice with a high amyloid burden, and wild type (WT) mice. Both mice strains fed with HFD showed impairment of recognition memory but when resveratrol was added to the HFD, recognition memory was restored. Moreover, our results indicate that HFD boosts amyloid pathology in both, WT and 5xFAD mice, mainly through the potentiation of the amyloidogenic pathway and the reduction of the non-amyloidogenic one. Namely, we identified an increase in β-secretase (BACE1) protein levels in both strains and a decrease in α-secretase (ADAM10) expression in WT mice after HFD administration. Tau pathology was as well aggravated in both strains. Interestingly, HFD has showed the capacity to enhance the activity of the ubiquitin-proteasome system, being the most significant changes the induction of proteasome caspase-like and chymotrypsin-like activities. Remarkably, resveratrol has demonstrated the capability to normalize all the pathological changes induced by the HFD in both WT and 5xFAD mice, confirming its preventive and therapeutic potential against neurodegeneration., SAF2016-77703-C2-2-R of the Ministerio de Economía y Competitividad, Spain and the European Regional Development Fund (ERDF); AGAUR 2017-SGR-106 and the CERCA Programme of the Generalitat de Catalunya; R. Copas and C. Sanfeliu belong to Group 05 of CIBER Epidemiología y Salud Pública (CIBERESP) of the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis de maestría (MasterThesis)

Lymphoblasts as potential peripheral biomarkers of Alzheimer's disease and the protective role of resveratrol

  • Senserrich, Júlia
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and first cause of dementia all over the world. It is characterized by a progressive neuronal loss. The main risk factor for developing AD is the age and it is known that there are shared pathological changes between them. Major pathological hallmarks include extracellular deposits of amyloid protein and intracellular deposits of neurofibrillary tau protein. Moreover, it is though that β-amyloid peptide induce cytotoxicity by the generation of reactive oxygen intermediates, contributing to protein tau’s hyperphosphorylation., The study used immortalised lymphocytes from patients of sporadic AD and age-matched healthy controls with following aims: First, use real-time PCR to verify the results of several genes expression analysed by array, in a previous study. Second, investigate the potential role of resveratrol, inducing an upregulation of genes involved in the antioxidant cell response and regulating the aging pathway. Finally, establish the different sensitivity between the human immortalized lymphocyte cell lines and human neuroblastoma cell lines, both treated with resveratrol and hydrogen peroxide (H2O2), an oxidative stress inductor., The current study was observed that gene expression results by PCR did not correlated with those obtained by array, suggesting a variability through individuals. Moreover, aging genes seemed to be more expressed by AD patients, but resveratrol did not induce any effect. Contrary to genes involved in an antioxidant response, which an upregulation induced by resveratrol was clearly demonstrated in most antioxidant genes tested. In addition, it was seen the high toxicity produced by an oxidative stress inductor and the trace that resveratrol 50µM could be the threshold of toxicity for neuronal cells, while lymphoblastomas showed to be more resistant to those compounds., SAF2016-77703-C2-2-R of the Ministerio de Economía y Competitividad, Spain and the European Regional Development Fund (ERDF); AGAUR 2017-SGR106 and the CERCA Programme of the Generalitat de Catalunya; C. Sanfeliu belong to Group 05 of CIBER Epidemiología y Salud Pública (CIBERESP) of the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis de maestría (MasterThesis)

Epoxide Hydrolase enzyme as a therapeutic target against Alzheimer's Disease

  • Almenara-Fuentes, Lidia
Alzheimer’s Disease (AD) represents a serious problem for the population health due to the increase in the life expectancy. Inflammation in AD is widely present and it is considered as a contributor to the cognitive loss and neurodegeneration. Epoxyeicosatrienoic acids (EETs) have anti-inflammatory properties which disappear when the enzyme soluble Epoxide Hydrolase (sEH) metabolizes them to the corresponding dihydroxyeicosatrienoic acids (DHETs). SEH is emerging as a promising pharmacological target because allows the increase of EETs and keep them active. The aim of the present study was to calculate the half maximal inhibitory concentration (IC50) of a newly synthetized sEH inhibitors (UB21, UB23, UB24, UB28, EPB50 and EV52), study their toxicity and the anti-inflammatory effects. SH-SY5Y cell cultures were used to the IC50 calculation and the toxicity of each sEHi. To study the inflammatory effects, lipopolysaccharide (LPS) stimulated microglial, BV2 cells were used to obtain conditioned media with the proinflammatory mediators. Modulation of the inflammatory pathways iNOS and NFĸB, and the release of proinflammatory cytokines were analyzed by techniques of Western Blot, immunocytochemistry and ELISA. All agents showed a higher inhibitory potency than the reference compound 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), being the IC50 of UB23 and UB28 at nanomolar range. EV52 could not been tested due to their random activity values. All sEHi were not cytotoxic at the anticipated concentrations, except EV52. The preliminary testing of anti-inflammatory effects unveils UB23 as the best candidate, SAF2016-77703-C2-2-R of the Ministerio de Economía y Competitividad, Spain and the European Regional Development Fund (ERDF); AGAUR 2017-SGR-106 and the CERCA Programme of the Generalitat de Catalunya; R. Copas and C. Sanfeliu belong to Group 05 of CIBER Epidemiología y Salud Pública (CIBERESP) of the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Modelling physical resilience in ageing mice

  • Schosserer, Markus
  • Banks, Gareth
  • Dogan, Soner
  • Dungel, Peter
  • Fernandes, Adelaide
  • Marolt Presen, Darja
  • Matheu, Ander
  • Osuchowski, Marcin
  • Potter, Paul
  • Sanfeliu, Coral
  • Guvenc Tuna, Bilge
  • Varela-Nieto, Isabel
  • Bellantuono, Ilaria
Geroprotectors, a class of drugs targeting multiple deficits occurring with age, necessitate the development of new animal models to test their efficacy. The COST Action MouseAGE is a European network whose aim is to reach consensus on the translational path required for geroprotectors, interventions targeting the biology of ageing. In our previous work we identified frailty and loss of resilience as a potential target for geroprotectors. Frailty is the result of an accumulation of deficits, which occurs with age and reduces the ability to respond to adverse events (physical resilience). Modelling frailty and physical resilience in mice is challenging for many reasons. There is no consensus on the precise definition of frailty and resilience in patients or on how best to measure it. This makes it difficult to evaluate available mouse models. In addition, the characterization of those models is poor. Here we review potential models of physical resilience, focusing on those where there is some evidence that the administration of acute stressors requires integrative responses involving multiple tissues and where aged mice showed a delayed recovery or a worse outcome then young mice in response to the stressor. These models include sepsis, trauma, drug- and radiation exposure, kidney and brain ischemia, exposure to noise, heat and cold shock., This article is based upon work from COST Action (BM1402: MouseAGE), supported by COST (European Cooperation in Science and Technology) and European Union Research and Innovation Program Horizon 2020 (GrantAgreement Number 730879). This work was supported by the Austrian Research Fund (FWF: P30623-B26), the Spanish MINECO (SAF2016-77703), the European Regional Development Fund, and the MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Peripheral Maintenance of the Axis SIRT1-SIRT3 at Youth Level May Contribute to Brain Resilience in Middle-Aged Amateur Rugby Players

  • Corpas, Rubén
  • Solana, Elisabeth
  • Rosa, Adrián de la
  • Sarroca, Sara
  • Griñán-Ferré, Christian
  • Oriol, Mireia
  • Corbella, Emili
  • Rodríguez-Farré, Eduard
  • Vina, Jose
  • Pallàs, Mercè
  • Bartrés-Faz, David
  • Gómez-Cabrera, M. C.
  • Sanfeliu, Coral
Physical exercise performed regularly is known to improve health and to reduce the risk of age-related diseases. Furthermore, there is some evidence of cognitive improvement in physically active middle-aged and older adults. We hypothesized that long-term physically active middle-aged men may have developed brain resilience that can be detected with the analysis of peripheral blood markers. We aimed to analyze the activation of pathways potentially modulated by physical activity in a cohort of healthy amateur rugby players (n = 24) and control subjects with low physical activity (n = 25) aged 45¿65 years. We had previously reported neuropsychological improvement in immediate memory responses in the player group compared to the controls. Here, we tested the expression of selected genes of longevity, inflammation, redox homeostasis, and trophic signaling in whole blood mRNA. Analyses were also performed on blood samples of young (aged 15¿25 years) control subjects with low physical activity (n = 21). Physical activity and other lifestyle factors were thoroughly recorded with standardized questionnaires. Interestingly, middle-aged control subjects showed lower levels of expression of SIRT1, SIRT3, CAT, and SOD1 than the young controls, although rugby players maintained the expression levels of these genes at a young-like level. Middle-aged players showed lower levels of IL1B than the non-physically active groups. However, there was a tendency towards a decrease in trophic and transduction factors in middle-aged groups as compared to the young controls. A statistical study of Spearman¿s correlations supported a positive effect of sporting activity on memory and executive functions, and on peripheral gene expression of SIRT1, SIRT3 and downstream genes, in the middle-aged rugby players. Our results indicate that the SIRT1-SIRT3 axis, and associated neuroprotective signaling, may contribute to the anti-aging resilience of the brain mediated by physical exercise., This work was supported by the following grants: Ajut Mario Sàlvia i Ferret 2014 de l’Institut d’Estudis Catalans (IEC), Barcelona, ‘‘Per Incentivar la Recerca en Biomedicina i Estil de Vida’’ (Grant to Incentivize the Research in Biomedicine and Lifestyles); SAF2016-77703 from the Spanish MINECO (Ministerio de Economía y Competitividad) and FEDER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement

  • Corpas, Rubén
  • Griñán-Ferré, Christian
  • Rodríguez-Farré, Eduard
  • Pallàs, Mercè
  • Sanfeliu, Coral
Resveratrol is a natural compound that mimics the antioxidant and antiaging effects of caloric restriction, mainly mediated through SIRT1, a deacetylase that induces longevity and neuroprotection. We aimed to analyze the effects of resveratrol on the brain status of control non-transgenic (NoTg) and AD transgenic (3xTg-AD) mice to discern the mechanisms involved in a potential inducement of resilience against age-related neurodegeneration and Alzheimer’s disease (AD). Mice were fed with a diet supplemented with 100 mg/kg of resveratrol from 2 months of age during 10 months. Resveratrol administration induced complete protection against memory loss and brain pathology in 3xTg-AD mice, and also induced cognitive enhancement in healthy NoTg mice. Resveratrol improved exploration and reduced anxiety in both mouse strains, indicative of well-being. Resveratrol reduced the presence of Aβ and p-tau pathology in the hippocampus of the 3xTg-AD mouse. Proteostasis analysis showed the following in both NoTg and 3xTg-AD mice: (i) increased levels of the amyloid-degrading enzyme neprilysin, (ii) reduction of the amyloidogenic secretase BACE1, and (iii) increase of proteasome protein levels and enhancement of proteasome activity. Resveratrol also increased AMPK protein levels, then upregulating the SIRT1 pathway, as shown by the activation of PGC-1α and CREB in both mice, resulting in further beneficial changes. Our data demonstrated that resveratrol induces cognitive enhancement and neuroprotection against amyloid and tau pathologies. Improvement of proteostasis by resveratrol, in both healthy and AD mice, suggests that it is a mechanism of brain resilience and defense against neurodegeneration caused by the accumulation of aberrant proteins., This study was supported by grants SAF2016-77703 and SAF2016-81716-REDC from Spanish MINECO and European Development Fund; 2017-SGR-106 from AGAUR and the CERCA Programme/Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Long-term physical activity induces brain resilience in middle-aged adults

  • Corpas, Rubén
  • Solana, Elisabeth
  • Rosa, Adrián de la
  • Sarroca, Sara
  • Griñán-Ferré, Christian
  • Oriol, Mireia
  • Corbella, Emili
  • Rodríguez-Farré, Eduard
  • Vina, Jose
  • Pallàs, Mercè
  • Bartrés-Faz, David
  • Gómez-Cabrera, M. C.
  • Sanfeliu, Coral
Trabajo presentado en la Jornada Científica CIBERESP (Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública), celebrada en Madrid (España), el 14 de noviembre de 2019, AIM: Physical activity practiced regularly is known to improve the well-being and to reduce the risk of age-related diseases. We aimed to determine the impact of long-term physical activity on memory maintenance and search for peripheral blood markers related to cognitive function that may be detectable at middle-age METHODS: We performed neuropsychological analyses to veteran amateur rugby players (n = 24, age: 46–68 y) and middleaged sedentary controls (n = 25, age: 47–67 y). We analyzed the expression of selected genes in whole blood mRNA of player and control groups and young sedentary controls (n = 21, age: 17–25 y). A young trained group (n = 16, age: 18–25 y) was added to analyze age-related response in circulating neurotrophins induced by chronic exercise, Ajut Mario Sàlvia i Ferret 2014, lnstitut d'Estudis Catalans; SAF2016‐77703, MINECO and ERDF; 2017-SGR-106, AGAUR.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Long-term sport practice induces brain resilience through SIRT1-SIRT3 axis in male veteran rugby players

  • Sanfeliu, Coral
  • Corpas, Rubén
  • Solana, Elisabeth
  • Rosa, Adrián de la
  • Sarroca, Sara
  • Griñán-Ferré, Christian
  • Oriol, Mireia
  • Corbella, Emili
  • Rodríguez-Farré, Eduard
  • Vina, Jose
  • Pallàs, Mercè
  • Bartrés-Faz, David
  • Gómez-Cabrera, M. C.
Trabajo presentado en el FENS Regional Meeting, celebrado en Belgrado (Sebia), del 10 al 13 de julio de 2019, Aim: Physical exercise performed regularly is known to improve health and to reduce the risk of age-related diseases. We had previously reported improved immediate memory responses in a cohort of veteran rugby players as compared to control subjects with low physical activity. We hypothesized that long-term physically active middle-aged men have developed brain resilience that can be detected with the analysis of peripheral blood markers. Methods: We tested the expression of selected genes of longevity, inflammation, redox homeostasis, and trophic signaling in whole blood mRNA. Analyses were performed on blood samples of veteran rugby players (n=24) and controls (n=25) aged 45-65 year, and also young controls (aged 15-25 years) with low physical activity (n=21). Physical activity and other lifestyles were thoroughly recorded with standardized questionnaires. Results: Middle-aged control subjects showed lower levels of expression of SIRT1, SIRT3 and CAT than the young controls, although rugby players maintained the expression levels of these genes at a young-like level. No differences were detected in the inflammatory genes, although there was a tendency towards a decrease in trophic and transduction factors in middle-aged groups as compared to the young controls. A statistical study of Spearman’s correlations supported a positive effect of sporting activity on memory and executive functions through SIRT1, SIRT3 and antioxidant gene expression levels in the veteran rugby players. Conclusions: Our results suggest the involvement of the SIRT1-SIRT3 axis, and the downstream antioxidant and neuroprotective signaling, in the anti-aging resilience of the brain mediated by physical exercise, Ajut Mario Sàlvia i Ferret 2014, lnstitut d’Estudis Catalans; SAF2016‐77703, MINECO and ERDF; 2017-SGR-106, AGAUR.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Mechanisms of monomeric C Reactive Protein inducing neurodegeneration

  • García-Lara, Elisa
  • Aguirre Infantes, Samuel
  • Clotet Perarnau, Núria
  • Corpas, Rubén
  • Slevin, Mark
  • Sanfeliu, Coral
Trabajo presentado en el FENS Regional Meeting, celebrado en Belgrado (Sebia), del 10 al 13 de julio de 2019, AIM: Neuroinflammation derived from ischemic damage increases the risk of both vascular dementia and Alzheimer¿s disease (AD). The monomeric C- reactive protein (mCRP) formed in the dissociation of the pentraxin CRP within the extracellular matrix of ischemic tissue, may be a causative link between stroke-associated inflammation and memory loss. We aimed to investigate the mechanism underlying neuroinflammation and loss of neuroplasticity induced by mCRP. METHODS: We used our established in vivo model of dementia by bilateral hippocampus injection of mCRP in C57BL/6j mice. Transgenic AD mice 5XFAD were used for comparison. Cell lines of microglia BV2 and HMC3 and neuroblastoma SH-SY5Y were treated with mCRP or CRP. Microglial cells were also treated with lipopolysaccharide. We assayed hippocampus tissue and cell culture extracts for gene expression and protein levels in a search of changes underlying neuroinflammation, neuroplasticity loss and neurodegeneration. RESULTS: In vivo treatment with mCRP induced long-term loss of learning and memory, analyzed up to 6 months. First molecular results revealed lower activation of signaling pathways related to plasticity early genes Arc and Egr1 in mCRP mice. Main changes in 5XFAD were related to oxidative stress and gliosis markers. A main effect on protein processing induced by mCRP was hyperphosphorylation of tau in AD-associated pathogenic residues such as Ser202 and Ser396. We are analyzing the protective effects of anti-inflammatory agents. CONCLUSIONS: Characterizing the mechanisms of mCRP-induced dementia might contribute to fight against AD incidence in the elderly., EU-COP 2014-2020, CRP-SAD, ID: P_37_674, MySMIS code: 103432, contract: 51/05.09.2016; SAF2016‐77703, MINECO and ERDF; 2017-SGR-106, AGAUR.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Mechanisms of neuroprotection of soluble epoxide hydrolase enzyme inhibition in Alzheimer's disease models

  • Corpas, Rubén
  • Clotet Perarnau, Núria
  • Aguirre Infantes, Samuel
  • García-Lara, Elisa
  • Slevin, Mark
  • Griñán-Ferré, Christian
  • Galdeano, Carles
  • Vázquez, Santiago
  • Suñol, Cristina
  • Pallàs, Mercè
  • Sanfeliu, Coral
Trabajo presentado en el FENS Regional Meeting, celebrado en Belgrado (Sebia), del 10 al 13 de julio de 2019, Aim: Chronic neuroinflammation associated with aging contributes to the onset and progression of Alzheimer’s disease (AD). Epoxyeicosatrienoic acids (EETs) are endogenous mediators that have several protective functions including antiinflammatory effects. EETs beneficial effects diminish when the enzyme soluble epoxide hydrolase (sEH) metabolizes them to the corresponding dihydroxyeicosatrienoic acids. Previous results showed that sEH inhibition mitigates cognitive impairment and AD-like brain pathology in SAMP8 and 5XFAD mouse models of senescence and AD, respectively. Here we investigate the underlying mechanisms of neuroinflammation and proteostasis changes related to cognitive loss and its neuroprotection by sEH inhibitors. Methods: We used the known sEH inhibitor TPPU and the compound newly synthesized UB-EV-52. sEH inhibitors were administered through drinking water in the 5XFAD transgenic AD mouse models. In in vitro experiments, they were added to the media of microglia cell lines BV2 and HCM3, and neuroblastoma SH-SY5Y, previously treated with lipopolysaccharide or monomeric C- reactive protein as proinflammatory stimulus. As endpoints we analyzed inflammatory and survival pathways, and changes in proteostasis. Results: Our findings confirmed the beneficial effects of sEH inhibition, reducing the cognitive impairment, increase of proteolytic mechanism against aberrant proteins with decline of Aβ and tau pathology, and decrease of inflammatory markers that suggests a protection against inflammaging. Moreover, UB-EV-52 agent showed higher inhibitory potency than TPPU and no cytotoxicity. Conclusion: These results reinforce sEH as promising pharmacological target to fight against AD and other brain diseases that might be triggered by inflammaging processes, SAF2016‐77703, MINECO and ERDF; EU-COP 2014-2020, CRP-SAD, ID: P_37_674, MySMIS code: 103432, contract: 51/05.09.2016; 2017-SGR-106, AGAUR; Caixaimpuls 2018.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms

  • Sarroca, Sara
  • Gatius, Alaó
  • Rodríguez-Farré, Eduard
  • Vilchez, David
  • Pallàs, Mercè
  • Griñán-Ferré, Christian
  • Sanfeliu, Coral
  • Corpas, Rubén
Cumulative evidence indicates that excessive consumption of calories from saturated fat contributes to the development of Alzheimer's disease (AD). Here, we assess the triggering and progression of AD pathology induced by a high-fat diet (HFD), and the effects of resveratrol, a polyphenol found in common dietary sources with pleiotropic neuroprotective activities. Over 16 weeks, male wild type (WT) and AD transgenic 5XFAD mice were fed a control diet, HFD (60% kcal from fat), or HFD supplemented with 0.1% resveratrol. Resveratrol protected against HFD-induced memory loss in WT mice and prevented memory loss in 5XFAD mice. Resveratrol also reduced the amyloid burden aggravated by HFD in 5XFAD, and protected against HFD-induced tau pathology in both WT and 5XFAD strains. At the mechanistic level, resveratrol inhibited the HFD-increased amyloidogenic processing of the amyloid precursor protein in both strains; it also restored abnormal high levels in the proteolytic activity of the ubiquitin-proteasome system induced by HFD, suggesting the presence of a compensatory mechanism to counteract the accumulation of aberrant proteins. Thus, our data suggest that resveratrol can correct the harmful effects of HFD in the brain and may be a potential therapeutic agent against obesity-related disorders and AD pathology., This research was funded by Spanish MINECO and European Regional Development Fund (grant number SAF2016-77703-C2); Spanish MCINN (grant number PID2019-106285RB); Catalan Autonomous Government AGAUR (grant number 2017-SGR-106); and the CERCA Programme/Generalitat de Catalunya., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis

  • Codony, Sandra
  • Calvó-Tusell, Carla
  • Valverde, Elena
  • Osuna, Sílvia
  • Morisseau, Christophe
  • Loza, M. Isabel
  • Brea, José
  • Pérez, Concepción
  • Rodríguez-Franco, María Isabel
  • Pizarro-Delgado, Javier
  • Corpas, Rubén
  • Griñán-Ferré, Christian
  • Pallàs, Mercè
  • Sanfeliu, Coral
  • Vázquez-Carrera, Manuel
  • Hammock, Bruce D.
  • Feixas, Ferran
  • Vázquez, Santiago
The pharmacological inhibition of soluble epoxide hydrolase (sEH) is efficient for the treatment of inflammatory and pain-related diseases. Numerous potent sEH inhibitors (sEHIs) present adamantyl or phenyl moieties, such as the clinical candidates AR9281 or EC5026. Herein, in a new series of sEHIs, these hydrophobic moieties have been merged in a benzohomoadamantane scaffold. Most of the new sEHIs have excellent inhibitory activities against sEH. Molecular dynamics simulations suggested that the addition of an aromatic ring into the adamantane scaffold produced conformational rearrangements in the enzyme to stabilize the aromatic ring of the benzohomoadamantane core. A screening cascade permitted us to select a candidate for an in vivo efficacy study in a murine model of cerulein-induced acute pancreatitis. The administration of 22 improved the health status of the animals and reduced pancreatic damage, demonstrating that the benzohomoadamantane unit is a promising scaffold for the design of novel sEHIs., This work was funded by the Spanish Ministerio de Economía, Industria y Competitividad (grants SAF2017-82771-R to S.V., RTI2018-093999-B-100 to M. V.-C., RTI2018-093955-B-C21 to M.I.R.-F., SAF2016-77703-C2 to M.P. and C.S., PGC2018- 102192-B-I00 to S.O. and RTI2018-101032-J-I00 to F.F.), the Spain EIT Health (Proof of concept 2016), the European Regional Development Fund (ERDF), the Xunta de Galicia (ED431G 2019/02 and ED431C 2018/21), the Fundació Bosch i Gimpera, Universitat de Barcelona (F2I grant), the Generalitat de Catalunya (2017 SGR 106, 2017 SGR 124 and 2017 SGR 1707), the European Research Council (ERC-2015-StG-679001-Net- MoDEzyme to S.O.), and the European Community (MSCA-IF- 2014-EF-661160-MetAccembly to F.F.). S.C. and E.V. acknowledge the PhD fellowships from the Universitat de Barcelona (APIF grant) and the Institute of Biomedicine of the University of Barcelona (IBUB), respectively. Partial support was provided by NIH-NIEHS River Award R35 ES03443, NIH-NIEHS Superfund Program P42 ES004699, NINDS R01 DK107767, and NIDDK R01 DK103616 to B.D.H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health., Peer reviewed